Company / Accounts Receivable
TransMedics Group, Inc. Accounts Receivable History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$84.3M
FY2025
5-year range
$5.9M / $97.7M
FY2021-FY2025
Trend
-13.8%
vs FY2024
Sector context
#104 of 143
Health Care
What the data says
At $84M, TransMedics Group, Inc.'s accounts receivable ranks #104 of 143 in the Health Care sector. Accounts Receivable has fluctuated over the past 8 years, ranging from $3M in FY2018 to $98M in FY2024.
Based on SEC 10-K filings.
$84M in FY2025 with a 5-year CAGR of +65.1%.
Improved from $64M to $84M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +45.1%
- 5-Year CAGR
- +65.1%
- 10-Year CAGR
- -
Sector benchmark
#104 of 143 in Health CareTop 73% of 143This company $84.3M Sector average $1.3B
▼
-93.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +65.1%, indicating consistent growth.
- In FY2025, accounts receivable decreased 13.8% year-over-year.
- Ranks #104 out of 143 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2024.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $84.3M | -13.8% |
| FY2024 | $97.7M | +53.7% |
| FY2023 | $63.6M | +130.3% |
| FY2022 | $27.6M | +365.3% |
| FY2021 | $5.9M | -13.5% |
| FY2020 | $6.9M | +4.7% |
| FY2019 | $6.6M | +90.8% |
| FY2018 | $3.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026